Standard BioTools Inc. - Common Stock (LAB)
1.2300
+0.00 (0.00%)
NASDAQ · Last Trade: Jun 24th, 4:32 AM EDT
This week, several emerging stocks are capturing investor attention with headline-making developments across defense tech, mining, HR, crypto gaming, wellness, and AI-driven diagnostics.
Via AB Newswire · June 23, 2025

Combination Builds Scale and Accelerates Path to Profitability, Unlocking Significant Potential Value for SomaLogic Stockholders
By SomaLogic · Via GlobeNewswire · December 21, 2023

Believes that the Proposed Merger Grossly Undervalues SomaLogic and Ignores its Revolutionary Products, Considerable Cash Position, and Strong Balance Sheet
By Skye Fund III, LLC · Via GlobeNewswire · December 20, 2023

NEW YORK, Dec. 17, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating the proposed all-stock merger between Standard BioTools Inc. (“Standard BioTools”) (NASDAQ: LAB) and SomaLogic, Inc. (“SomaLogic”) (NASDAQ: SLGC).
By Lowey Dannenberg, P.C. · Via GlobeNewswire · December 17, 2023

NEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating the proposed all-stock merger between Standard BioTools Inc. (“Standard BioTools”) (NASDAQ: LAB) and SomaLogic, Inc. (“SomaLogic”) (NASDAQ: SLGC).
By Lowey Dannenberg, P.C. · Via GlobeNewswire · December 11, 2023

NEW YORK, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating the proposed all-stock merger between Standard BioTools Inc. (“Standard BioTools”) (NASDAQ: LAB) and SomaLogic, Inc. (“SomaLogic”) (NASDAQ: SLGC).
By Lowey Dannenberg, P.C. · Via GlobeNewswire · December 6, 2023

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of SomaLogic, Inc. (NasdaqGM: SLGC) to Standard BioTools Inc. (“the Company”) (NasdaqGS: LAB). Under the terms of the proposed transaction, upon closing of the proposed transaction, Standard BioTools shareholders will own approximately 43% of the combined company. KSF is seeking to determine whether the transaction and the process that led to it are adequate and fair to the Company’s shareholders.
By Kahn Swick & Foti, LLC · Via Business Wire · December 5, 2023

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of SomaLogic, Inc. (NasdaqGM: SLGC) to Standard BioTools Inc. (“the Company”) (NasdaqGS: LAB). Under the terms of the proposed transaction, upon closing of the proposed transaction, Standard BioTools shareholders will own approximately 43% of the combined company. KSF is seeking to determine whether the transaction and the process that led to it are adequate and fair to the Company’s shareholders.
By Kahn Swick & Foti, LLC · Via Business Wire · October 6, 2023

BALA CYNWYD, Pa., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · October 4, 2023

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Standard BioTools Inc. (NASDAQ: LAB) and SomaLogic, Inc. is fair to Standard BioTools shareholders. Under the terms of the agreement, SomaLogic shareholders will receive 1.11 shares of Standard BioTools common stock for each share of SomaLogic common stock owned. Upon closing of the proposed transaction, Standard BioTools shareholders will own approximately 43% of the combined company.
By Halper Sadeh LLC · Via Business Wire · October 4, 2023